How many institutions held VBIO - Valion Bio, Inc. - Common Stock, par value $0.0001 per share in Q2 2025?

4 institutional investors reported VBIO - Valion Bio, Inc. - Common Stock, par value $0.0001 per share for Q2 2025. Use the holders table for investor-level position and value details.

Valion Bio, Inc. - Common Stock, par value $0.0001 per share (VBIO)

Q: What does CUSIP 888705308 represent in this 13F holders report?

CUSIP 888705308 is the security identifier for VBIO - Valion Bio, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

CUSIP: 888705308

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 3,106,323
Total 13F shares: 44,961
Share change: +5,657
Total reported value: $186,587
Price per share: $4.14
Number of holders: 4
Value change: +$23,476
Number of buys: 2

Security key

888705308

Report period

Q2 2025

Institutions

Top holders

VBIO full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2025 Previous quarter: Q1 2025 Valion Bio, Inc. SEC filings Valion Bio, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 888705308

Newer quarter: Q3 2025 Previous quarter: Q1 2025

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025

Ownership snapshot

Top shareholders of VBIO - Valion Bio, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

SBI Securities Co., Ltd.

13D/G signal

—

Evidence rows

Latest as of

31 Mar 2025

13F 3/4/5 Lead comparable stake: 0% Showing first 8 of 9 holder rows. Open remaining rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
SBI Securities Co., Ltd.	13F Company 13F	0%	$41 16 shares	—	31 Mar 2025
BANK OF AMERICA CORP /DE/	13F Company 13F	0%	$13 5 shares	—	31 Mar 2025
John Claude	3/4/5 10%+ Owner 3/4/5	— class O/S missing	— 1,196,000 shares	—	10 Nov 2021
Blake Gurfein	3/4/5 Chief Scientific Officer 3/4/5	— mixed-class rows	— 235,000 shares mixed-class rows	—	18 Dec 2024
Veronica Cai	3/4/5 Chief Financial Officer 3/4/5	— class O/S missing	— 117,880 shares	—	01 Apr 2022
Briana Benz	3/4/5 Chief Financial Officer 3/4/5	— class O/S missing	— 112,500 shares	—	10 Nov 2021
Ryan Sabia	3/4/5 Chief Operating Officer 3/4/5	— class O/S missing	— 100,000 shares	—	08 May 2023
Kimberly Ann Bambach	3/4/5 Interim CFO 3/4/5	— class O/S missing	— 7,500 shares	—	01 Oct 2024

Show 1 additional holder rows in the full holder list

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Karen Drexler	3/4/5 Director 3/4/5	— class O/S missing	— 3,000 shares	—	30 Sep 2024

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

44,961

Rows loaded

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders

Q2 2025 holders

Holder diff

Investor	Q1 2025 Shares	Q2 2025 Shares	Share Diff	Share Chg %	Q1 2025 value	Q2 2025 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend